| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Music | 54 | 2023 | 75 | 12.170 |
Why?
|
| Stroke | 61 | 2026 | 1325 | 6.740 |
Why?
|
| Brain | 72 | 2026 | 1601 | 5.790 |
Why?
|
| Transcranial Direct Current Stimulation | 14 | 2026 | 16 | 5.270 |
Why?
|
| Motor Cortex | 32 | 2026 | 72 | 4.620 |
Why?
|
| Recovery of Function | 26 | 2026 | 291 | 4.520 |
Why?
|
| Magnetic Resonance Imaging | 108 | 2025 | 2241 | 4.410 |
Why?
|
| Functional Laterality | 43 | 2018 | 140 | 3.950 |
Why?
|
| Neuronal Plasticity | 22 | 2025 | 151 | 3.690 |
Why?
|
| Brain Mapping | 36 | 2012 | 239 | 3.480 |
Why?
|
| Stroke Rehabilitation | 14 | 2026 | 51 | 3.440 |
Why?
|
| Pitch Perception | 17 | 2023 | 25 | 3.430 |
Why?
|
| Pitch Discrimination | 13 | 2012 | 13 | 2.830 |
Why?
|
| Psychomotor Performance | 15 | 2017 | 137 | 2.760 |
Why?
|
| Aphasia | 8 | 2025 | 47 | 2.710 |
Why?
|
| Learning | 14 | 2012 | 186 | 2.550 |
Why?
|
| Auditory Perception | 12 | 2021 | 43 | 2.460 |
Why?
|
| Deglutition Disorders | 6 | 2022 | 43 | 2.360 |
Why?
|
| Speech | 11 | 2022 | 62 | 2.180 |
Why?
|
| Aphasia, Broca | 5 | 2022 | 12 | 2.140 |
Why?
|
| Pyramidal Tracts | 9 | 2020 | 25 | 2.120 |
Why?
|
| Autistic Disorder | 6 | 2022 | 154 | 2.000 |
Why?
|
| Music Therapy | 9 | 2022 | 15 | 1.990 |
Why?
|
| Speech Therapy | 4 | 2022 | 16 | 1.980 |
Why?
|
| Motor Activity | 11 | 2021 | 344 | 1.910 |
Why?
|
| Cerebral Cortex | 13 | 2016 | 268 | 1.890 |
Why?
|
| Male | 169 | 2025 | 31020 | 1.810 |
Why?
|
| Memory, Short-Term | 5 | 2021 | 62 | 1.750 |
Why?
|
| Motor Skills | 11 | 2012 | 61 | 1.750 |
Why?
|
| Cerebrovascular Circulation | 15 | 2021 | 183 | 1.700 |
Why?
|
| Humans | 223 | 2026 | 65168 | 1.680 |
Why?
|
| Female | 154 | 2025 | 33982 | 1.610 |
Why?
|
| Nerve Net | 12 | 2021 | 100 | 1.590 |
Why?
|
| Acoustic Stimulation | 17 | 2020 | 62 | 1.530 |
Why?
|
| Transcranial Magnetic Stimulation | 8 | 2020 | 27 | 1.500 |
Why?
|
| Adult | 117 | 2021 | 17331 | 1.440 |
Why?
|
| Diffusion Tensor Imaging | 14 | 2020 | 77 | 1.400 |
Why?
|
| Upper Extremity | 6 | 2021 | 54 | 1.320 |
Why?
|
| Language Development Disorders | 4 | 2021 | 26 | 1.290 |
Why?
|
| Exercise Therapy | 2 | 2025 | 102 | 1.260 |
Why?
|
| Electric Stimulation Therapy | 4 | 2012 | 28 | 1.260 |
Why?
|
| Corpus Callosum | 9 | 2016 | 42 | 1.240 |
Why?
|
| Image Processing, Computer-Assisted | 31 | 2018 | 697 | 1.200 |
Why?
|
| Brain Ischemia | 20 | 2018 | 418 | 1.170 |
Why?
|
| Autism Spectrum Disorder | 3 | 2022 | 180 | 1.170 |
Why?
|
| Speech Disorders | 4 | 2021 | 18 | 1.060 |
Why?
|
| Electric Stimulation | 6 | 2011 | 139 | 1.020 |
Why?
|
| Occupational Therapy | 3 | 2012 | 12 | 1.020 |
Why?
|
| White Matter | 7 | 2024 | 126 | 1.000 |
Why?
|
| Prefrontal Cortex | 8 | 2023 | 126 | 1.000 |
Why?
|
| Memory | 6 | 2005 | 123 | 0.980 |
Why?
|
| Aged | 71 | 2025 | 14949 | 0.960 |
Why?
|
| Middle Aged | 72 | 2025 | 18252 | 0.930 |
Why?
|
| Nervous System Diseases | 4 | 2020 | 106 | 0.930 |
Why?
|
| Image Interpretation, Computer-Assisted | 12 | 2026 | 187 | 0.850 |
Why?
|
| Language Therapy | 2 | 2016 | 13 | 0.840 |
Why?
|
| Child, Preschool | 14 | 2022 | 2059 | 0.820 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 8 | 2026 | 164 | 0.820 |
Why?
|
| Electroencephalography | 9 | 2020 | 156 | 0.810 |
Why?
|
| Child | 23 | 2022 | 4606 | 0.810 |
Why?
|
| Aging | 5 | 2017 | 768 | 0.810 |
Why?
|
| Neurogenesis | 2 | 2018 | 64 | 0.810 |
Why?
|
| Brain Injuries | 6 | 2026 | 141 | 0.800 |
Why?
|
| Parietal Lobe | 5 | 2021 | 28 | 0.780 |
Why?
|
| Dominance, Cerebral | 12 | 2012 | 31 | 0.780 |
Why?
|
| Cerebellum | 4 | 2017 | 93 | 0.770 |
Why?
|
| Treatment Outcome | 22 | 2026 | 5783 | 0.760 |
Why?
|
| Connectome | 3 | 2021 | 37 | 0.760 |
Why?
|
| Severity of Illness Index | 13 | 2015 | 1554 | 0.740 |
Why?
|
| Tissue Plasminogen Activator | 9 | 2008 | 243 | 0.740 |
Why?
|
| Young Adult | 22 | 2021 | 4811 | 0.740 |
Why?
|
| Hand | 7 | 2008 | 76 | 0.730 |
Why?
|
| Anisotropy | 5 | 2016 | 63 | 0.720 |
Why?
|
| Sensorimotor Cortex | 1 | 2021 | 4 | 0.690 |
Why?
|
| Temporal Lobe | 11 | 2023 | 46 | 0.680 |
Why?
|
| Movement | 7 | 2008 | 163 | 0.630 |
Why?
|
| Cerebral Hemorrhage | 6 | 2019 | 100 | 0.630 |
Why?
|
| Deglutition | 3 | 2018 | 20 | 0.620 |
Why?
|
| Cognition | 5 | 2006 | 507 | 0.590 |
Why?
|
| Problem Solving | 2 | 2009 | 32 | 0.590 |
Why?
|
| Creativity | 2 | 2017 | 14 | 0.580 |
Why?
|
| Neural Pathways | 7 | 2021 | 101 | 0.560 |
Why?
|
| Aphasia, Conduction | 1 | 2018 | 1 | 0.560 |
Why?
|
| Child Behavior | 1 | 2018 | 65 | 0.550 |
Why?
|
| Adolescent | 24 | 2021 | 6296 | 0.530 |
Why?
|
| Dancing | 1 | 2017 | 12 | 0.530 |
Why?
|
| Time Factors | 22 | 2015 | 3873 | 0.520 |
Why?
|
| Spinal Cord | 1 | 2018 | 209 | 0.510 |
Why?
|
| Evoked Potentials, Motor | 6 | 2018 | 21 | 0.510 |
Why?
|
| Korsakoff Syndrome | 1 | 2016 | 1 | 0.500 |
Why?
|
| Electrodes | 5 | 2023 | 39 | 0.500 |
Why?
|
| Cerebral Infarction | 8 | 2013 | 85 | 0.490 |
Why?
|
| Neurons | 6 | 2010 | 931 | 0.470 |
Why?
|
| Blindness | 3 | 2008 | 43 | 0.470 |
Why?
|
| Feedback, Sensory | 1 | 2015 | 8 | 0.460 |
Why?
|
| Aged, 80 and over | 34 | 2018 | 5606 | 0.460 |
Why?
|
| Singing | 2 | 2025 | 2 | 0.440 |
Why?
|
| Analysis of Variance | 8 | 2016 | 602 | 0.430 |
Why?
|
| Language | 5 | 2022 | 154 | 0.430 |
Why?
|
| Verbal Behavior | 3 | 2016 | 36 | 0.420 |
Why?
|
| Emotions | 6 | 2022 | 233 | 0.420 |
Why?
|
| Physical Therapy Modalities | 2 | 2012 | 46 | 0.410 |
Why?
|
| Afferent Pathways | 1 | 2013 | 15 | 0.410 |
Why?
|
| Cerebrum | 2 | 2010 | 16 | 0.410 |
Why?
|
| Echo-Planar Imaging | 8 | 2006 | 34 | 0.410 |
Why?
|
| Tomography, Emission-Computed | 19 | 1998 | 43 | 0.400 |
Why?
|
| Fibrinolytic Agents | 4 | 2006 | 178 | 0.390 |
Why?
|
| Auditory Pathways | 2 | 2012 | 7 | 0.390 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2009 | 297 | 0.390 |
Why?
|
| Dystonic Disorders | 2 | 2004 | 8 | 0.390 |
Why?
|
| Gyrus Cinguli | 5 | 2006 | 59 | 0.380 |
Why?
|
| Sleep | 3 | 2005 | 240 | 0.380 |
Why?
|
| Task Performance and Analysis | 4 | 2012 | 129 | 0.370 |
Why?
|
| Predictive Value of Tests | 10 | 2016 | 1113 | 0.370 |
Why?
|
| Apraxias | 3 | 2021 | 7 | 0.360 |
Why?
|
| Functional Neuroimaging | 1 | 2012 | 16 | 0.360 |
Why?
|
| Prognosis | 10 | 2019 | 1783 | 0.360 |
Why?
|
| Neuropsychological Tests | 8 | 2009 | 410 | 0.360 |
Why?
|
| Frontal Lobe | 5 | 2014 | 63 | 0.350 |
Why?
|
| Thrombolytic Therapy | 6 | 2008 | 194 | 0.350 |
Why?
|
| Prosopagnosia | 2 | 2023 | 2 | 0.340 |
Why?
|
| Hemispherectomy | 2 | 2021 | 2 | 0.330 |
Why?
|
| Linguistics | 1 | 2010 | 22 | 0.330 |
Why?
|
| Psychoacoustics | 2 | 2008 | 3 | 0.330 |
Why?
|
| Chronic Disease | 6 | 2024 | 741 | 0.330 |
Why?
|
| Fingers | 6 | 2021 | 48 | 0.330 |
Why?
|
| Deep Brain Stimulation | 1 | 2011 | 68 | 0.330 |
Why?
|
| Visual Perception | 5 | 2016 | 46 | 0.320 |
Why?
|
| Gastrostomy | 1 | 2010 | 30 | 0.320 |
Why?
|
| Motor Skills Disorders | 1 | 2010 | 5 | 0.320 |
Why?
|
| Enteral Nutrition | 1 | 2010 | 53 | 0.320 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2010 | 74 | 0.320 |
Why?
|
| Association Learning | 1 | 2009 | 8 | 0.310 |
Why?
|
| Psychophysics | 1 | 2009 | 9 | 0.310 |
Why?
|
| Epilepsy | 4 | 2018 | 113 | 0.310 |
Why?
|
| Verbal Learning | 1 | 2009 | 21 | 0.310 |
Why?
|
| Somatosensory Cortex | 6 | 2003 | 20 | 0.310 |
Why?
|
| Social Behavior | 1 | 2010 | 85 | 0.300 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2009 | 30 | 0.300 |
Why?
|
| Spin Labels | 2 | 2021 | 12 | 0.300 |
Why?
|
| Amygdala | 2 | 2008 | 84 | 0.290 |
Why?
|
| Reference Values | 10 | 2008 | 326 | 0.290 |
Why?
|
| Aptitude | 1 | 2008 | 10 | 0.290 |
Why?
|
| Deafness | 1 | 2009 | 36 | 0.290 |
Why?
|
| Retrospective Studies | 19 | 2014 | 6859 | 0.280 |
Why?
|
| Models, Neurological | 4 | 2005 | 83 | 0.280 |
Why?
|
| Diffusion | 9 | 2007 | 82 | 0.280 |
Why?
|
| Combined Modality Therapy | 2 | 2025 | 372 | 0.280 |
Why?
|
| Longitudinal Studies | 5 | 2013 | 1282 | 0.270 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2006 | 140 | 0.270 |
Why?
|
| Case-Control Studies | 6 | 2012 | 1140 | 0.270 |
Why?
|
| Prospective Studies | 12 | 2016 | 3310 | 0.270 |
Why?
|
| Patient Selection | 4 | 2010 | 483 | 0.260 |
Why?
|
| Hepatolenticular Degeneration | 3 | 1996 | 6 | 0.260 |
Why?
|
| Feedback, Psychological | 1 | 2007 | 15 | 0.250 |
Why?
|
| Double-Blind Method | 4 | 2014 | 738 | 0.250 |
Why?
|
| Auditory Cortex | 3 | 2016 | 12 | 0.250 |
Why?
|
| Sex Characteristics | 5 | 2003 | 214 | 0.240 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2026 | 11 | 0.240 |
Why?
|
| Wakefulness | 3 | 2005 | 43 | 0.240 |
Why?
|
| Auditory Perceptual Disorders | 2 | 2023 | 2 | 0.230 |
Why?
|
| Cerebral Peduncle | 2 | 2016 | 2 | 0.230 |
Why?
|
| Cognition Disorders | 2 | 2007 | 223 | 0.230 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 2478 | 0.230 |
Why?
|
| Reaction Time | 5 | 2008 | 130 | 0.220 |
Why?
|
| Clinical Protocols | 2 | 2014 | 253 | 0.220 |
Why?
|
| Affect | 2 | 2020 | 132 | 0.220 |
Why?
|
| Pilot Projects | 4 | 2016 | 1014 | 0.220 |
Why?
|
| Periaqueductal Gray | 1 | 2004 | 4 | 0.210 |
Why?
|
| Linear Models | 4 | 2013 | 405 | 0.210 |
Why?
|
| Magnetics | 3 | 2004 | 53 | 0.210 |
Why?
|
| Brain Chemistry | 3 | 2011 | 76 | 0.210 |
Why?
|
| Glucose | 9 | 1997 | 474 | 0.210 |
Why?
|
| Behavior | 1 | 2004 | 36 | 0.210 |
Why?
|
| Sex | 1 | 2003 | 5 | 0.200 |
Why?
|
| Serial Learning | 1 | 2003 | 5 | 0.200 |
Why?
|
| Oxygen | 5 | 2011 | 318 | 0.200 |
Why?
|
| Multivariate Analysis | 5 | 2013 | 929 | 0.200 |
Why?
|
| Risk Factors | 11 | 2014 | 5425 | 0.190 |
Why?
|
| Hemorrhage | 1 | 2005 | 285 | 0.190 |
Why?
|
| Language Tests | 2 | 2014 | 39 | 0.190 |
Why?
|
| Range of Motion, Articular | 2 | 2015 | 113 | 0.190 |
Why?
|
| Neurological Rehabilitation | 1 | 2022 | 1 | 0.190 |
Why?
|
| Regression Analysis | 4 | 2016 | 497 | 0.190 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2002 | 7 | 0.190 |
Why?
|
| Cerebrovascular Disorders | 3 | 1997 | 83 | 0.180 |
Why?
|
| Neurosciences | 2 | 2012 | 27 | 0.180 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2002 | 87 | 0.170 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 17 | 0.170 |
Why?
|
| Evoked Potentials | 2 | 2020 | 39 | 0.170 |
Why?
|
| Checklist | 1 | 2022 | 72 | 0.170 |
Why?
|
| ROC Curve | 4 | 2012 | 292 | 0.170 |
Why?
|
| Biophysics | 2 | 2012 | 42 | 0.160 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2020 | 7 | 0.160 |
Why?
|
| Speech-Language Pathology | 1 | 2020 | 10 | 0.160 |
Why?
|
| Occupations | 3 | 2006 | 52 | 0.160 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 205 | 0.160 |
Why?
|
| Boston | 5 | 2014 | 258 | 0.160 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 219 | 0.160 |
Why?
|
| Speech Perception | 3 | 2019 | 79 | 0.150 |
Why?
|
| Healthy Volunteers | 2 | 2017 | 72 | 0.150 |
Why?
|
| Motor Disorders | 1 | 2019 | 4 | 0.150 |
Why?
|
| Demography | 3 | 2005 | 178 | 0.140 |
Why?
|
| Infant, Newborn | 2 | 2026 | 1418 | 0.140 |
Why?
|
| Pandemics | 2 | 2020 | 675 | 0.140 |
Why?
|
| Disability Evaluation | 4 | 2015 | 216 | 0.140 |
Why?
|
| Disease Progression | 4 | 2016 | 1219 | 0.140 |
Why?
|
| Brain Stem | 1 | 2018 | 30 | 0.140 |
Why?
|
| Receptors, Dopamine D2 | 2 | 1996 | 22 | 0.140 |
Why?
|
| Telemedicine | 2 | 2020 | 363 | 0.140 |
Why?
|
| Logistic Models | 2 | 2012 | 1269 | 0.140 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 87 | 0.140 |
Why?
|
| Photic Stimulation | 6 | 2016 | 89 | 0.130 |
Why?
|
| Cross-Over Studies | 5 | 2025 | 164 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2020 | 262 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2703 | 0.130 |
Why?
|
| Risk Assessment | 5 | 2010 | 2098 | 0.130 |
Why?
|
| Professional Competence | 1 | 2017 | 92 | 0.120 |
Why?
|
| Attention | 3 | 2006 | 150 | 0.120 |
Why?
|
| Observer Variation | 3 | 2012 | 216 | 0.120 |
Why?
|
| Pleasure | 1 | 2016 | 13 | 0.120 |
Why?
|
| Rest | 1 | 2016 | 45 | 0.120 |
Why?
|
| Individuality | 1 | 2016 | 23 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 433 | 0.120 |
Why?
|
| Rats | 3 | 2018 | 1993 | 0.120 |
Why?
|
| Penicillamine | 2 | 1995 | 2 | 0.120 |
Why?
|
| Nervous System | 1 | 1996 | 71 | 0.120 |
Why?
|
| Epilepsies, Partial | 4 | 1996 | 18 | 0.120 |
Why?
|
| Statistics as Topic | 2 | 2013 | 147 | 0.120 |
Why?
|
| Reward | 1 | 2016 | 89 | 0.110 |
Why?
|
| Perception | 2 | 2023 | 181 | 0.110 |
Why?
|
| Risk | 4 | 2012 | 374 | 0.110 |
Why?
|
| Biomarkers | 3 | 2018 | 1479 | 0.110 |
Why?
|
| Gait | 1 | 2015 | 121 | 0.110 |
Why?
|
| Contrast Media | 2 | 2008 | 431 | 0.100 |
Why?
|
| Tinnitus | 1 | 2014 | 17 | 0.100 |
Why?
|
| Eating | 1 | 2014 | 139 | 0.100 |
Why?
|
| Parkinson Disease | 1 | 2015 | 135 | 0.100 |
Why?
|
| Perfusion | 2 | 2007 | 75 | 0.100 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2013 | 7 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2006 | 186 | 0.100 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2006 | 352 | 0.100 |
Why?
|
| Probability | 1 | 2013 | 170 | 0.100 |
Why?
|
| Long QT Syndrome | 1 | 2013 | 31 | 0.100 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2013 | 27 | 0.100 |
Why?
|
| Pyramidal Cells | 1 | 1993 | 27 | 0.100 |
Why?
|
| Acute Disease | 9 | 2011 | 662 | 0.100 |
Why?
|
| Walking | 1 | 2015 | 245 | 0.100 |
Why?
|
| Perceptual Disorders | 1 | 2013 | 7 | 0.100 |
Why?
|
| Deoxyglucose | 4 | 1997 | 32 | 0.100 |
Why?
|
| Golgi Apparatus | 1 | 1993 | 65 | 0.100 |
Why?
|
| Efferent Pathways | 1 | 2012 | 9 | 0.090 |
Why?
|
| Reproducibility of Results | 6 | 2022 | 1695 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2014 | 129 | 0.090 |
Why?
|
| Animals | 11 | 2018 | 21292 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2012 | 148 | 0.090 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2002 | 117 | 0.090 |
Why?
|
| Image Enhancement | 3 | 1998 | 194 | 0.090 |
Why?
|
| Magnetoencephalography | 4 | 2003 | 7 | 0.090 |
Why?
|
| Prosencephalon | 3 | 1997 | 36 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 2 | 2009 | 120 | 0.090 |
Why?
|
| Deferoxamine | 1 | 2011 | 5 | 0.090 |
Why?
|
| Odds Ratio | 2 | 2010 | 753 | 0.090 |
Why?
|
| Speech Production Measurement | 1 | 2011 | 6 | 0.090 |
Why?
|
| Creatinine | 2 | 2009 | 135 | 0.090 |
Why?
|
| Neurologic Examination | 2 | 2010 | 54 | 0.090 |
Why?
|
| Registries | 3 | 2013 | 923 | 0.090 |
Why?
|
| Cerebral Angiography | 3 | 2010 | 299 | 0.090 |
Why?
|
| Gestures | 1 | 2011 | 3 | 0.090 |
Why?
|
| Particulate Matter | 1 | 2012 | 70 | 0.090 |
Why?
|
| Syndrome | 2 | 2009 | 178 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2011 | 142 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2008 | 1653 | 0.080 |
Why?
|
| Safety | 1 | 2011 | 143 | 0.080 |
Why?
|
| Coffee | 1 | 2010 | 18 | 0.080 |
Why?
|
| Physical Exertion | 1 | 2010 | 81 | 0.080 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 88 | 0.080 |
Why?
|
| Water | 2 | 2002 | 313 | 0.080 |
Why?
|
| Occipital Lobe | 2 | 2006 | 17 | 0.080 |
Why?
|
| Algorithms | 2 | 2026 | 1046 | 0.080 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2009 | 18 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2026 | 804 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2009 | 1163 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 2 | 2026 | 159 | 0.070 |
Why?
|
| Space Perception | 3 | 2005 | 19 | 0.070 |
Why?
|
| History, 19th Century | 1 | 2008 | 40 | 0.070 |
Why?
|
| Vocabulary | 1 | 2008 | 20 | 0.070 |
Why?
|
| Reperfusion | 2 | 2007 | 37 | 0.070 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2010 | 110 | 0.070 |
Why?
|
| Touch | 1 | 2008 | 27 | 0.070 |
Why?
|
| Visual Cortex | 1 | 2008 | 27 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 36 | 0.070 |
Why?
|
| Brain Infarction | 1 | 2008 | 21 | 0.070 |
Why?
|
| Action Potentials | 1 | 2008 | 113 | 0.070 |
Why?
|
| Ferritins | 1 | 2008 | 29 | 0.070 |
Why?
|
| Models, Cardiovascular | 2 | 2007 | 83 | 0.070 |
Why?
|
| Brain Edema | 1 | 2008 | 29 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 1997 | 102 | 0.070 |
Why?
|
| Air Pollutants | 1 | 2009 | 99 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 131 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2008 | 232 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 320 | 0.070 |
Why?
|
| Electromagnetic Fields | 2 | 2004 | 15 | 0.060 |
Why?
|
| United States | 5 | 2020 | 8209 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 458 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2008 | 177 | 0.060 |
Why?
|
| Paralysis | 1 | 2006 | 17 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2005 | 213 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2009 | 226 | 0.060 |
Why?
|
| Models, Statistical | 2 | 2009 | 309 | 0.060 |
Why?
|
| Kidney | 1 | 2009 | 451 | 0.060 |
Why?
|
| Age Factors | 2 | 2009 | 1584 | 0.060 |
Why?
|
| Feedback | 1 | 2006 | 91 | 0.060 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2026 | 27 | 0.060 |
Why?
|
| Blood Circulation | 1 | 2006 | 8 | 0.060 |
Why?
|
| Cell Size | 2 | 1997 | 41 | 0.060 |
Why?
|
| Social Perception | 1 | 2005 | 43 | 0.060 |
Why?
|
| Spiperone | 2 | 1996 | 2 | 0.060 |
Why?
|
| Butanols | 2 | 1996 | 2 | 0.060 |
Why?
|
| Phonetics | 1 | 2005 | 26 | 0.060 |
Why?
|
| Arteries | 1 | 2006 | 81 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2005 | 49 | 0.060 |
Why?
|
| Awareness | 1 | 2005 | 73 | 0.060 |
Why?
|
| Survival Rate | 2 | 2009 | 843 | 0.060 |
Why?
|
| Canada | 1 | 2005 | 271 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2005 | 85 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 57 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 213 | 0.050 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 17 | 0.050 |
Why?
|
| Evoked Potentials, Somatosensory | 2 | 2002 | 8 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2014 | 2618 | 0.050 |
Why?
|
| Gray Matter | 1 | 2024 | 38 | 0.050 |
Why?
|
| Machine Learning | 1 | 2026 | 192 | 0.050 |
Why?
|
| Judgment | 1 | 2004 | 37 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 2004 | 30 | 0.050 |
Why?
|
| Exercise | 1 | 2010 | 963 | 0.050 |
Why?
|
| Surveys and Questionnaires | 4 | 2014 | 2756 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1185 | 0.050 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 204 | 0.050 |
Why?
|
| Caudate Nucleus | 1 | 2002 | 25 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 277 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 124 | 0.050 |
Why?
|
| Isometric Contraction | 1 | 2002 | 47 | 0.050 |
Why?
|
| Carotid Stenosis | 1 | 2004 | 100 | 0.050 |
Why?
|
| Bias | 1 | 2023 | 115 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2026 | 882 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 159 | 0.050 |
Why?
|
| Intracranial Thrombosis | 1 | 2002 | 28 | 0.050 |
Why?
|
| Thalamus | 1 | 2002 | 77 | 0.040 |
Why?
|
| Dystonia | 1 | 2002 | 13 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2293 | 0.040 |
Why?
|
| Basal Ganglia | 3 | 1996 | 34 | 0.040 |
Why?
|
| Seizures | 1 | 2002 | 141 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 101 | 0.040 |
Why?
|
| Body Water | 1 | 1999 | 15 | 0.040 |
Why?
|
| Stents | 1 | 2004 | 498 | 0.040 |
Why?
|
| Primates | 3 | 1996 | 52 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 1999 | 73 | 0.040 |
Why?
|
| Amnesia | 1 | 1999 | 9 | 0.040 |
Why?
|
| Blood Volume | 1 | 1999 | 40 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 74 | 0.040 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 1996 | 20 | 0.040 |
Why?
|
| Psychological Tests | 1 | 2019 | 47 | 0.040 |
Why?
|
| S100 Proteins | 1 | 2018 | 20 | 0.040 |
Why?
|
| Hominidae | 1 | 1998 | 7 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2011 | 174 | 0.030 |
Why?
|
| Education, Medical | 1 | 2020 | 182 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 65 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 181 | 0.030 |
Why?
|
| Oxygen Radioisotopes | 2 | 1996 | 4 | 0.030 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 1997 | 6 | 0.030 |
Why?
|
| Epilepsy, Complex Partial | 1 | 1996 | 4 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 1997 | 196 | 0.030 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 1996 | 1 | 0.030 |
Why?
|
| Basal Ganglia Diseases | 1 | 1996 | 5 | 0.030 |
Why?
|
| Esthetics | 1 | 2016 | 19 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 1996 | 104 | 0.030 |
Why?
|
| Neostriatum | 1 | 1996 | 26 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1996 | 49 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1996 | 18 | 0.030 |
Why?
|
| Macaca | 1 | 1995 | 30 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 1995 | 21 | 0.030 |
Why?
|
| Foot Orthoses | 1 | 2015 | 6 | 0.030 |
Why?
|
| Autoradiography | 4 | 1996 | 52 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2015 | 17 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 729 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2010 | 984 | 0.030 |
Why?
|
| Cell Count | 2 | 1993 | 128 | 0.030 |
Why?
|
| Silver Staining | 1 | 1995 | 5 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 1995 | 72 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1995 | 48 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 1994 | 11 | 0.030 |
Why?
|
| Fluorine Radioisotopes | 1 | 1994 | 8 | 0.030 |
Why?
|
| Smartphone | 1 | 2015 | 73 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2015 | 128 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 111 | 0.030 |
Why?
|
| Exercise Test | 1 | 2015 | 257 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2015 | 140 | 0.020 |
Why?
|
| Sex Factors | 3 | 2005 | 991 | 0.020 |
Why?
|
| Color Perception | 1 | 2013 | 4 | 0.020 |
Why?
|
| Dendrites | 1 | 1993 | 60 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 750 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 585 | 0.020 |
Why?
|
| Hypotension | 1 | 2011 | 50 | 0.020 |
Why?
|
| British Columbia | 1 | 2010 | 5 | 0.020 |
Why?
|
| Weight Lifting | 1 | 2010 | 13 | 0.020 |
Why?
|
| North Carolina | 1 | 2010 | 69 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 553 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 236 | 0.020 |
Why?
|
| Headache | 1 | 2010 | 58 | 0.020 |
Why?
|
| Medical Records | 1 | 2010 | 140 | 0.020 |
Why?
|
| Health Surveys | 1 | 2010 | 316 | 0.020 |
Why?
|
| Sensory Deprivation | 1 | 2008 | 3 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 36 | 0.020 |
Why?
|
| Contraindications | 1 | 2008 | 52 | 0.020 |
Why?
|
| Orientation | 1 | 2008 | 25 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2008 | 20 | 0.020 |
Why?
|
| Temperament | 1 | 2008 | 20 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2010 | 529 | 0.020 |
Why?
|
| Hair | 1 | 2008 | 81 | 0.020 |
Why?
|
| Hematoma | 1 | 2008 | 84 | 0.020 |
Why?
|
| Reading | 1 | 2008 | 95 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 740 | 0.020 |
Why?
|
| Iron | 1 | 2008 | 154 | 0.020 |
Why?
|
| Tectum Mesencephali | 1 | 2006 | 2 | 0.020 |
Why?
|
| Expressed Emotion | 1 | 2006 | 3 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 481 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2006 | 30 | 0.010 |
Why?
|
| Sound | 1 | 2005 | 9 | 0.010 |
Why?
|
| Radiography | 2 | 2002 | 555 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 463 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2006 | 274 | 0.010 |
Why?
|
| Endarterectomy, Carotid | 1 | 2004 | 79 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 195 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 112 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2008 | 1149 | 0.010 |
Why?
|
| Forearm | 1 | 1998 | 22 | 0.010 |
Why?
|
| Sleep Stages | 1 | 1998 | 19 | 0.010 |
Why?
|
| Scalp | 1 | 1998 | 29 | 0.010 |
Why?
|
| Electromyography | 1 | 1998 | 99 | 0.010 |
Why?
|
| Body Height | 1 | 1998 | 65 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1998 | 31 | 0.010 |
Why?
|
| Stereognosis | 1 | 1997 | 2 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1998 | 116 | 0.010 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1997 | 2 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1998 | 218 | 0.010 |
Why?
|
| Artifacts | 1 | 1998 | 126 | 0.010 |
Why?
|
| Neuropil | 1 | 1996 | 6 | 0.010 |
Why?
|
| Body Weight | 1 | 1998 | 375 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 128 | 0.010 |
Why?
|
| Embolism | 1 | 1997 | 41 | 0.010 |
Why?
|
| Thromboembolism | 1 | 1997 | 74 | 0.010 |
Why?
|
| Age of Onset | 1 | 1996 | 173 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2004 | 1322 | 0.010 |
Why?
|
| Gadolinium | 1 | 1997 | 110 | 0.010 |
Why?
|
| Intelligence | 1 | 1996 | 51 | 0.010 |
Why?
|
| Species Specificity | 2 | 1986 | 336 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 198 | 0.010 |
Why?
|
| Anthropometry | 1 | 1995 | 86 | 0.010 |
Why?
|
| Recurrence | 1 | 1997 | 655 | 0.010 |
Why?
|
| Drug Overdose | 1 | 1996 | 122 | 0.010 |
Why?
|
| Penicillins | 1 | 1994 | 32 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1994 | 182 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1994 | 69 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 785 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 1994 | 139 | 0.010 |
Why?
|
| Models, Structural | 1 | 1992 | 25 | 0.010 |
Why?
|
| Thumb | 1 | 1992 | 27 | 0.010 |
Why?
|
| Mouth | 1 | 1992 | 35 | 0.010 |
Why?
|
| Foot | 1 | 1992 | 42 | 0.010 |
Why?
|
| Infant | 1 | 1994 | 1692 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1986 | 128 | 0.000 |
Why?
|